With a new €120M Infusion, Pocket NGS CEO talks Success and Strategy
Seeking to disrupt the NGS market, Oxford Nanopore is rolling in cash. Before we heard…
As one of the biggest success stories of the 21st century, gene therapy is providing hope for treating diseases that once seemed incurable. Any genetic mutation causing disease could theoretically be fixed by inserting a new copy of the faulty gene. This means that gene therapy has the potential to treat some previously incurable conditions with a single dose.
By 2025, the FDA expects to approve between 10 and 20 gene therapies each year, and we are already seeing an increase in the number of approvals today. However, the field continues to face a number of obstacles ranging from safety concerns to manufacturing shortages. Read on to get the latest in the gene therapy field.
Gene Therapy Industry Report 2021
In this report, we take a closer look at the growing gene therapy market, current development and manufacturing challenges, and the exciting future ahead for this industry.
Go to ReportSeeking to disrupt the NGS market, Oxford Nanopore is rolling in cash. Before we heard…
Oxford BioMedica and Orchard Therapeutics are partnering up to bring gene therapy to the market…
UniQure just announced a new R&D plan designed to save up to €27M over the…
How do you solve a problem like lentiviral vector infections? CEVEC has done it. We…
How far away is biotech from a breakthrough with cell and gene therapy? While these…
A new method of gene sequencing has brought us an HIV diagnostic on a "USB…
CEVEC just filed a Biologics Master File (BB-MF) to the FDA for its CAP technology,…
By this point, you can’t have escaped hearing about CRISPR. First discovered in the 1980’s, the repeated…
Koen Vanmechelen is an artist that works in the intersection of art and research. His…
Artios Pharma, launched in May this year, just received €29M (£25M) in Series A to develop…
Genenta Science and Amgen have teamed up to develop gene therapies for cancer. The Italian…
There were many exciting developments for CNS disease treatments last year, and now a French…